Detalles de la búsqueda
1.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
N Engl J Med
; 383(18): 1711-1723, 2020 10 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955177
2.
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat
; 188(2): 369-377, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125340
3.
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer.
Future Oncol
; 17(35): 4827-4835, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34723634
4.
Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy.
Support Care Cancer
; 28(11): 5335-5342, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32128615
5.
Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study.
Support Care Cancer
; 25(2): 459-464, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27714530
6.
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
JAMA
; 317(1): 37-47, 2017 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27918780
7.
Favorable outcome of immunotherapy in a rare subtype of hepatocellular carcinoma: a case report and literature review.
Front Oncol
; 14: 1358804, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715785
8.
Pituitary metastasis from renal cell carcinoma: a case report with literature review.
J Med Assoc Thai
; 96 Suppl 2: S257-61, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23590051
9.
A phase II study of the combination of gemcitabine plus carboplatin as the neoadjuvant treatment in locally advanced breast cancer.
J Med Assoc Thai
; 96 Suppl 2: S67-74, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23590024
10.
Cost-Utility and Budget Impact Analyses of Oral Chemotherapy for Stage III Colorectal Cancer: Real-World Evidence after Policy Implementation in Thailand.
Cancers (Basel)
; 15(20)2023 Oct 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37894297
11.
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non-Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial.
J Clin Oncol
; 41(10): 1830-1840, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720083
12.
Randomized, double-blinded, placebo-controlled trial of ondansetron plus dexamethasone with or without metoclopramide as antiemetic prophylaxis in patients receiving high-dose cisplatin in medical practice.
Support Care Cancer
; 20(4): 849-55, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21505898
13.
Clinical characteristics and disease outcome of UICC stages I-III colorectal cancer patients at Siriraj Hospital.
J Med Assoc Thai
; 95 Suppl 2: S189-98, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22574549
14.
C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study).
J Med Assoc Thai
; 95 Suppl 2: S199-207, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22574550
15.
Primary pulmonary lymphoepithelioma-like carcinoma treated with immunotherapy: A case report and literature review.
Thorac Cancer
; 13(17): 2539-2541, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35830974
16.
Loss of CDX-2 expression is an independent poor prognostic biomarker in patients with early-stage deficient mismatch repair colorectal cancer.
Asia Pac J Clin Oncol
; 18(3): 249-258, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161647
17.
Low Fat-Free Mass Index Measured by Bioelectrical Impedance Analysis Correlates With Hematologic Adverse Events in Early-Stage Breast Cancer Patients Receiving Chemotherapy: A Prospective Observational Cohort Study.
Technol Cancer Res Treat
; 21: 15330338221106529, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695243
18.
Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study.
Front Oncol
; 12: 813009, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35242708
19.
Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial.
Clin Cancer Res
; 28(11): 2286-2296, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012927
20.
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC.
J Thorac Oncol
; 17(3): 423-433, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34740861